High Tower Advisors, LLC Novo Cure LTD Call Options Transaction History

High Tower Advisors, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 06, 2021	BUY	$130.4 - $225.58 $12,909 - $22,332	99 Added 9900.0%	100 $1,000
Q4 2020 Feb 10, 2021	SELL	$112.16 - $174.14 $55,967 - $86,895	-499 Reduced 99.8%	1 $3,000
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $23,220 - $44,524	400 Added 400.0%	500 $10,000
Q2 2020 Aug 10, 2020	SELL	$57.2 - $74.41 $34,320 - $44,646	-600 Reduced 85.71%	100 $0
Q1 2020 May 21, 2020	BUY	$57.05 - $95.75 $34,230 - $57,450	600 Added 600.0%	700 $1,000
Q3 2018 Nov 09, 2018	SELL	$32.0 - $52.4 $3,200 - $5,240	-100 Reduced 50.0%	100 $1,000
Q2 2018 Aug 14, 2018	SELL	$19.85 - $32.0 $13,895 - $22,400	-700 Reduced 77.78%	200 $1,000
Q1 2018 May 15, 2018	BUY	$19.3 - $23.65 $17,370 - $21,285	900 New	900 $1,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.